Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
₹ 1.9
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very low or no dividends
Data is available to registered users only
Data is available to registered users only
About
Vivanza Biosciences Ltd. engages in the manufacture and trade of pharmaceutical products. Its product includes Intravenous (IV) Fusion. The company was founded on March 03, 1982 and is headquartered in Ahmedabad, India.
Company Valuation
Based on key historical and expected multiples, the stock is slightly overvalued relative to its peers. Specifically, the stock is overvalued on EV/EBITDA.
Data is available to registered users only
Buy
Sell